Latest News for: eye disease

Edit

Weight Loss Drug Linked to Lower Risk of Eye Disease in Patients with Diabetes (NewYork-Presbyterian Hospital)

Public Technologies 13 Feb 2026
The findings may offer comfort to patients concerned about their eye health while taking the drug ... As a result, the tirzepatide group had a reduced need for eye treatments such as intraocular injections or laser therapy.
Edit

Weight-loss drug linked to lower eye-disease risk in patients with diabetes (Cornell University)

Public Technologies 12 Feb 2026
The findings may offer comfort to patients concerned about their eye health while taking the drug ... As a result, the tirzepatide group had a reduced need for eye treatments such as intraocular injections or laser therapy.
Edit

Silent Eye Disease In India: Why AMD Cases Are Increasing, Can It Be Prevented After 40?

News18 07 Feb 2026
India is seeing a rise in AMD as its population ages, life expectancy increases and lifestyle factors change. Data shows AMD prevalence among Indians over 40 is from 1.8% to 4.7% ....
Edit

DEOSS International Conference on Dry Eye Disease to be held in Bengaluru on January 31

The Hindu 30 Jan 2026
The event will bring together leading specialists and researchers to discuss the latest advancements in the diagnosis and management of ocular surface disorders ....
Edit

TRYPTYR by Aerie Pharmaceuticals expected to drive market size of Dry Eye Disease

GetNews 29 Jan 2026
TRYPTYR™ (Acoltremon) is an investigational topical eye therapy in development for dry eye disease (DED), targeting a large and expanding market with significant unmet medical needs ... Dry Eye Disease (Primary Indication) ... Dry Eye Disease Pipeline.
Edit

Dry Eye Disease Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies ...

GetNews 21 Jan 2026
“Dry Eye Disease Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Dry Eye Disease Market.
Edit

A blinding parasitic eye disease affects mostly contact lens wearers. Here’s how to avoid it

CNN 10 Jan 2026
Teresa Sanchez was in Mexico for a medical procedure nearly four years ago when she kept feeling dry, poking sensations in her right eye ... An eye specialist later confirmed Sanchez’s suspicion.
Edit

A hidden cellular breakdown may be driving dry eye disease

Science Daily 03 Jan 2026
Dry eye disease affects millions of people, causing burning, redness, and constant eye ...
Edit

Thyroid Eye Disease (TED) Treatments Market Nears $4.3 Billion by 2032: Emerging Small Molecule Therapies ...

Business Wire 20 Dec 2025
DUBLIN--(BUSINESS WIRE)--The "Thyroid Eye Disease Treatments Market - Global Forecast 2025-2032" ...
Edit

Thyroid Eye Disease (TED) Treatments Market Nears $4.3 Billion by 2032: Emerging Small Molecule Therapies Targeting Orbital Fibroblasts Drive Revenue Growth - ResearchAndMarkets.com

Pharmiweb 20 Dec 2025
DUBLIN--(BUSINESS WIRE)--The "Thyroid Eye Disease Treatments Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering ... Thyroid Eye Disease Treatments Market.
Edit

Thyroid Eye Disease Treatments Industry Analysis, 2025-2032 - Clinical Management is Shifting Toward Individualized Care ...

Nasdaq Globe Newswire 17 Dec 2025
Dublin, Dec. 17, 2025 (GLOBE NEWSWIRE) -- The "Thyroid Eye Disease Treatments Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering ... .
Edit

GenSci and RTW Investments Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and Thyroid Eye Disease, With Global Ex-China Development Being Led by Yarrow Bioscience

Pharmiweb 16 Dec 2025
exclusive global ex-China rights to develop and commercialize GS-098 (YB-101) for Graves’ disease (GD) and thyroid eye disease (TED) ... treatment of Graves’ disease (GD) and thyroid eye disease (TED).
Edit

Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease (Form 8-K) (Aldeyra Therapeutics Inc)

Public Technologies 16 Dec 2025
Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease ... New Drug Application (NDA) for the treatment of dry eye disease.
Edit

Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease

Pharmiweb 16 Dec 2025
Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target action date for the reproxalap New Drug Application (NDA) for the treatment of dry eye disease.
Edit

argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease (Zai Lab Ltd)

Public Technologies 15 Dec 2025
... evaluating efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in adults with moderate to severe thyroid eye disease (TED) will be discontinued.

Article Search

tools
×
×
×
×